Psyence Biomedical Ltd. (PBM)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
4. 32
+0.19
+4.6005%
Pre Market
$
+0.56 +12.963% 4. 88
94.52K Market Cap
- P/E Ratio
- Div Yield
16,494 Volume
0 Eps
$ 4.13
Previous Close Want to track PBM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Psyence Biomedical Ltd. (PBM) Statistics
Valuation metrics
Market Cap 94.52K
Enterprise value -7.35M
Trailing P/E (ttm) -0.4
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.16
Enterprise Value/Revenue -
Enterprise Value/EBITDA 1.06
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 51.12K
Average volume (90 days) 72.93K
Price summary
52-Week low 1.92
52-Week high 139.06
Beta -
50-Day moving average 5.18
200-Day moving average 4.27
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 2 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.39%
Return on equity -0.59%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -12.56
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.48
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 14.62%
Book value per share (mrq) 30.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
